TSND.F Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
TerrAscend Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.64 |
| 52 Week High | CA$2.45 |
| 52 Week Low | CA$1.29 |
| Beta | 1.98 |
| 1 Month Change | -4.65% |
| 3 Month Change | -21.53% |
| 1 Year Change | 8.15% |
| 3 Year Change | -85.20% |
| 5 Year Change | -73.38% |
| Change since IPO | 35.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSND.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -10.4% | 0.08% | 1.2% |
| 1Y | 8.2% | 13.2% | 24.9% |
Return vs Industry: TSND.F underperformed the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: TSND.F underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| TSND.F volatility | |
|---|---|
| TSND.F Average Weekly Movement | 10.5% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TSND.F's share price has been volatile over the past 3 months.
Volatility Over Time: TSND.F's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
| TSND.F fundamental statistics | |
|---|---|
| Market cap | US$592.94m |
| Earnings (TTM) | -US$91.10m |
| Revenue (TTM) | US$317.33m |
1.5x
P/S Ratio-5.3x
P/E RatioIs TSND.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSND.F income statement (TTM) | |
|---|---|
| Revenue | US$317.33m |
| Cost of Revenue | US$157.63m |
| Gross Profit | US$159.70m |
| Other Expenses | US$250.80m |
| Earnings | -US$91.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 50.33% |
| Net Profit Margin | -28.71% |
| Debt/Equity Ratio | 85.8% |
How did TSND.F perform over the long term?
See historical performance and comparison